OrbiMed Capital LLCDeclared Swiss shareholdings
OrbiMed Capital LLC: 0 Swiss companies with a declared holding. Latest filing: 18.03.2004.
- Estimated value (CHF)
- —
- Swiss companies held
- 0
- Largest position
- —
- 12-month trend
- Not determinable
- 0 rate rises · 0 rate falls
- Latest filing
- 18.03.2004
- Active since 2004
Declared Swiss portfolio
Latest declared rate per company
No active declared position.
How to read these figures?
Rates come from the 3 official filings published by SIX Exchange Regulation. A filing is only required when a threshold is crossed (3, 5, 10, 15, 20, 25, 33⅓, 50, 66⅔%): the actual position may have changed since.
Estimated value = shares held per the latest filing × latest CHF closing price. It is an indicative order of magnitude: the position may have changed without a new threshold being crossed, and holdings without a share count or a CHF price are not valued. Each company's mini-chart traces the successive declared rates.
This profile shows only what the declarant published. No external data is added to it.
Group structure
Shareholding disclosures are often filed jointly by several entities of the same group. The registry links them together: "Controls" lists the group entities declared alongside this shareholder, "Controlled by" the head entities. The figure is the number of joint disclosures, followed by the date of the most recent one.
Show group structure8 controlled by · 1 controls
Controlled by
Group entities that file jointly with this shareholder as its head.
- Eaton Vance Worldwide Health Sciences Portfolio1 · 02.02.2006
- PHARMA/wHEALTH Management Company S.A1 · 02.02.2006
- PaineWebberEucalyptus Fund LLC1 · 02.02.2006
- PaineWebberEucalyptus Fund Ltd1 · 02.02.2006
- Caduceus Capital II L.P1 · 02.02.2006
- Caduceus Capital Trust Ltd1 · 02.02.2006
- Finsbury Worldwide Pharmaceutical Trust PLC1 · 02.02.2006
- Eaton Vance Emerald Worldwide Health Science Fund1 · 14.12.2005
This mapping reflects observed disclosures; it does not necessarily indicate permanent legal control.
Disclosure behaviour
Upward and downward threshold crossings show direction, without measuring daily trades below legal thresholds.
90 days · Upward crossings
0
visible history: 0
90 days · Downward crossings
0
visible history: 0
Nature of disclosed positions
Derivatives, sale positions or lending may indicate a more complex strategy than a long equity holding.
Latest shareholding disclosures
Berna Biotech AG
OrbiMed Capital LLC · Group of shareholders
Berna Biotech AG
OrbiMed Capital LLC · Group of shareholders
Actelion Ltd
OrbiMed Capital LLC · Group of shareholders
insider24.ch
Follow OrbiMed Capital LLC’s disclosures
Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.
Need more? Discover the Pro plan
Common questions
Which Swiss companies are in OrbiMed Capital LLC’s disclosed portfolio?
No active holding identified in available disclosures.
What is OrbiMed Capital LLC’s latest disclosure?
The latest available disclosure was published on 02.02.2006 and concerns Berna Biotech AG. Threshold disclosures do not describe every purchase or sale.
Explore further
Recent insider purchases
What are insiders doing at companies disclosed by this shareholder?
All purchases this weekInsider barometer
Compare insider purchases and sales across the Swiss stock exchange over 30 days.
View the Swiss barometerThese signals are not investment advice.